Kezar Life Sciences Ownership | Who Owns Kezar Life Sciences?


OverviewForecastFinancialsChart

Kezar Life Sciences Ownership Summary


Kezar Life Sciences is owned by 21.27% institutional investors, 10.57% insiders, and 68.16% retail investors. Tang capital management is the largest institutional shareholder, holding 9.85% of KZR shares. International Biotechnology Ord is the top mutual fund, with 4.80% of its assets in Kezar Life Sciences shares.

KZR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKezar Life Sciences21.27%10.57%68.16%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management720.00K9.85%$2.81M
Bml capital management720.79K9.84%$4.53M
Suvretta capital management716.76K9.80%$2.80M
Stonepine capital management383.18K5.24%$1.49M
Vanguard group341.40K4.66%$2.15M
Nantahala capital management276.75K3.78%$1.74M
Orbimed advisors192.70K2.64%$751.53K
Renaissance131.28K1.79%$825.78K
Peapod lane capital126.70K1.73%$796.94K
Acadian asset management125.37K1.71%$787.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management720.79K3.92%$4.53M
Stonepine capital management383.18K1.21%$1.49M
Peapod lane capital126.70K0.68%$796.94K
Qiming u.s. ventures management82.87K0.58%$323.20K
Aldebaran capital80.63K0.45%$507.16K
Nano cap new millennium growth fund l p25.00K0.13%$157.25M
Tang capital management720.00K0.11%$2.81M
Fny investment advisers50.00K0.09%$314.00K
Suvretta capital management716.76K0.07%$2.80M
Nantahala capital management276.75K0.06%$1.74M

Top Buyers

HolderShares% AssetsChange
Nantahala capital management276.75K0.06%276.75K
Stonepine capital management383.18K1.21%213.32K
Aldebaran capital80.63K0.45%80.63K
Vanguard group341.40K-73.24K
Bank of america corp /de/105.39K-72.14K

Top Sellers

HolderShares% AssetsChange
Blackrock830.37K--3.79M
Acuitas investments---1.23M
Avidity partners management lp---502.60K
Schroder investment management group---350.39K
Nuveen asset management---314.76K

New Positions

HolderShares% AssetsChangeValue
Nantahala capital management276.75K0.06%276.75K$1.74M
Aldebaran capital80.63K0.45%80.63K$507.16K
Mackenzie financial58.71K0.00%58.71K$35.23K
Fny investment advisers50.00K0.09%50.00K$314.00K
Nano cap new millennium growth fund l p25.00K0.13%25.00K$157.25M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-13.00
Nisa investment advisors-50.00
Citigroup-51.00
Simplex trading-400.00
Capital advisors-1.61K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202514-64.10%1,557,500-62.97%210.64%7-46.15%4-42.86%
Sep 30, 202511-70.27%1,385,694-68.97%180.51%5-58.33%2-75.00%
Jun 30, 202538-7.32%4,475,0783.39%611.74%13-8-46.67%
Mar 31, 20254-90.91%478,385-88.55%619.94%--100.00%1-96.97%
Dec 31, 20241-98.28%3,686-99.99%-0.02%--100.00%1-95.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
International Biotechnology Ord350.39K4.80%-
Vanguard Total Stock Mkt Idx Inv223.23K3.05%-
Biotech Growth Ord192.70K2.63%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc693.06K0.95%-100.25K
Vanguard Institutional Extnd Mkt Idx Tr67.30K0.92%-
Bridgeway Ultra-Small Company51.64K0.71%10.64K
Vifag 2002 SICAV45.00K0.62%-
Fidelity Extended Market Index34.78K0.48%1.67K
NT Ext Equity Mkt Idx Fd - DC - NL - T233.98K0.47%104.00
Fidelity Nasdaq Composite Index32.48K0.45%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 02, 2025Chiang Pichi Luo SVP, Corporate ControllerSell$1.13K
Jul 02, 2025Schiller Mark C. Chief Operating OfficerSell$2.40K
Jul 02, 2024Schiller Mark C. Chief Legal OfficerSell$3.88K
Feb 06, 2023Morningside Venture Investments Ltd-Sell$275.32K
Feb 03, 2023Morningside Venture Investments Ltd-Sell$178.65K

Insider Transactions Trends


DateBuySell
2025 Q3-2
2025 Q2--
2025 Q1--
2024 Q3-1
2024 Q2--

KZR Ownership FAQ


Who Owns Kezar Life Sciences?

Kezar Life Sciences shareholders are primarily institutional investors at 21.27%, followed by 10.57% insiders and 68.16% retail investors. The average institutional ownership in Kezar Life Sciences's industry, Biotech Stocks , is 381.47%, which Kezar Life Sciences falls below.

Who owns the most shares of Kezar Life Sciences?

Kezar Life Sciences’s largest shareholders are Tang capital management (720K shares, 9.85%), Bml capital management (720.79K shares, 9.84%), and Suvretta capital management (716.76K shares, 9.80%). Together, they hold 29.49% of Kezar Life Sciences’s total shares outstanding.

Does Blackrock own Kezar Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Kezar Life Sciences.

Who is Kezar Life Sciences’s biggest shareholder by percentage of total assets invested?

Bml capital management is Kezar Life Sciences’s biggest shareholder by percentage of total assets invested, with 3.92% of its assets in 720.79K Kezar Life Sciences shares, valued at 4.53M$.

Who is the top mutual fund holder of Kezar Life Sciences shares?

International Biotechnology Ord is the top mutual fund holder of Kezar Life Sciences shares, with 4.80% of its total shares outstanding invested in 350.39K Kezar Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools